MICROBAL MUSINGS

Temple Health University Health System investigators recently used an innovative approach that could pave the way for strategies to improve the ectiveness and safety of kinase inhibitors.

 

Temple Health investigators recently used an innovative approach that could pave the way for strategies to improve the ectiveness and safety of kinase inhibitors. Kinases are proteins that play a key role in a variety of cell processes, including growth, metabolism, and death. Because these processes often go awry in cancer cells, the development of kinase inhibitors is a major focus of cancer research. However, these drugs can cause adverse side e ects in patients or become less effective over time.

“These mutated kinases can act like entirely new beasts, resistant to drugs and relentlessly driving the growth of cancer,” says senior investigator Je rey R. Peterson, associate professor in the Cancer Biology Program at Fox Chase. 

Temple Health investigators recently used an innovative approach that could pave the way for strategies to improve the ectiveness and safety of kinase inhibitors. Kinases are proteins that play a key role in a variety of cell processes, including growth, metabolism, and death. Because these processes often go awry in cancer cells, the development of kinase inhibitors is a major focus of cancer research. However, these drugs can cause adverse side e ects in patients or become less effective over time.

INNOVATIVE APPROACH

Temple Health investigators recently used an innovative approach that could pave the way for strategies to improve the ectiveness and safety of kinase inhibitors. Kinases are proteins that play a key role in a variety of cell processes, including growth, metab- olism, and death. Because these processes often go awry in cancer cells, the development of kinase inhibitors is a major focus of cancer research. However, these drugs can cause adverse side e ects in patients or become less e ective over time.

“These mutated kinases can act like entirely new beasts, resistant to drugs and relentlessly driving the growth of cancer,” says senior investigator Je rey R. Peterson, associate professor in the Cancer Biology Program at Fox Chase. 

Fox Chase Cancer Center investigators recently used an innovative approach that could pave the way for strategies to improve the e ectiveness and safety of kinase inhibitors. Kinases are proteins that play a key role in a variety of cell processes, including growth, metabolism, and death. Because these processes often go awry in cancer cells, the development of kinase inhibitors is a ma- jor focus of cancer research. However, these drugs can cause adverse side e ects in patients or become less e ective over time.

“These mutated kinases can act like entirely new beasts, resistant to drugs and relentlessly driving the growth of cancer,” says senior inves- tigator Je rey R. Peterson, associate professor in the Cancer Biology Program at Fox Chase.Fox Chase Cancer Center investigators recently used an innovative approach that could pave the way for strategies to improve the e ectiveness and safety of kinase inhibitors. Kinases are proteins that play a key role in a variety of cell processes, including growth, metabolism, and death. Because these processes often go awry in cancer cells, the development of kinase inhibitors is a major focus of cancer research.

CANCER BIOLOGY PROGRAM

Fox Chase Cancer Center investigators recently used an innovative approach that could pave the way for strategies to improve the ectiveness and safety of kinase inhibitors. Kinases are proteins that play a key role in a variety of cell processes, including growth, metab- olism, and death. Because these processes often go awry in cancer cells, the development of kinase inhibitors is a major focus of cancer research. However, these drugs can cause adverse side e ects in patients or become less e ective over time.

“These mutated kinases can act like entirely new beasts, resistant to drugs and relentlessly driving the growth of cancer,” says senior investigator Je rey R. Peterson, associate professor in the Cancer Biology Program at Fox Chase. 

Fox Chase Cancer Center investigators recently used an innovative approach that could pave the way for strategies to improve the ectiveness and safety of kinase inhibitors. Kinases are proteins that play a key role in a variety of cell processes, including growth, metabolism, and death. Because these processes often go awry in cancer cells, the development of kinase inhibitors is a major focus of cancer research. However, these drugs can cause adverse side e ects in patients or become less e ective over time.